Clinical

The defined time interval during which a specific drug strength or concentration value is considered valid or active within formulary management or drug database systems. Used to manage effective date ranges for drug strength records across pharmacy benefit and medication management platforms.

A telephone contact number associated with a specific drug strength record, typically referencing the manufacturer, distributor, or pharmacy contact responsible for that drug concentration. Used in drug database management to support supply chain, safety reporting, or formulary administration workflows.

The standardized or preferred human-readable label used to display a drug concentration value in clinical and pharmacy systems. Ensures consistent naming of medication strengths across formularies, drug databases, prescription labels, and clinical documentation to reduce medication errors.

The monetary cost associated with a specific drug strength or concentration, representing the unit or dispensing price used in pharmacy benefit management, formulary pricing, and drug procurement systems. Used to support reimbursement calculations, cost analysis, and pricing negotiations for medications at a defined potency.

A flag or Boolean indicator that designates a specific drug concentration as the primary or preferred strength within a drug record or formulary. Used in pharmacy and drug database systems to distinguish the default strength from alternative concentrations when multiple options exist for the same medication.

A ranking value that determines the order of preference or processing sequence for a specific drug strength within formulary management or pharmacy benefit systems. Used to guide clinical decision support, drug selection logic, and formulary tiering when multiple concentrations of a medication are available.

The date on which a clinical procedure or treatment associated with a specific drug strength was performed. Used in clinical and claims systems to link medication concentrations to procedure events, supporting utilization review, outcomes tracking, and pharmacy-related claims adjudication.

A heart rate measurement recorded in association with a specific drug concentration, typically captured to document a patient's cardiovascular status at the time a medication strength was administered or evaluated. Used in clinical documentation to support pharmacovigilance and medication response monitoring.

The numeric count or volume of a drug at a specific concentration that was dispensed, prescribed, or recorded within a pharmacy or clinical system. Used in pharmacy claims, medication management, and drug database systems to quantify the amount of a particular drug strength supplied per transaction or prescription fill.

The racial or ethnic classification associated with a patient record linked to a specific drug strength entry. Used in clinical research, pharmacogenomics, and population health analytics to analyze medication dosing patterns, therapeutic responses, and health equity outcomes across demographic groups.

The minimum and maximum allowable concentration values defined for a specific drug strength within clinical or pharmacy systems. Used to establish therapeutic dosing boundaries, support clinical decision support alerts, and validate drug concentration entries against acceptable pharmacological limits in medication management platforms.

The per-unit pricing or reimbursement rate associated with a specific drug concentration within pharmacy benefit management and claims adjudication systems. Used to calculate total payment amounts for dispensed medications and support contract negotiations, formulary pricing analysis, and pharmacy cost reporting.

An evaluative score or classification assigned to a specific drug concentration based on clinical efficacy, formulary tier, or therapeutic equivalence criteria. Used in pharmacy benefit management and formulary systems to rank or assess the relative value, safety, or preference level of a medication at a defined strength.

The proportional relationship between active ingredient and total formulation volume for a medication, expressing concentration as a ratio (e.g., 1:1000). Used in pharmacy dispensing systems to standardize drug strength comparisons across different formulation types and dosage forms.

The clinical or operational justification for a specific drug concentration selection, such as renal dose adjustment, pediatric weight-based dosing, or formulary substitution. Captured in pharmacy and medication management systems to document why a particular strength was prescribed or dispensed.

The calendar date on which a specific drug strength or concentration record was received into the pharmacy inventory or medication database. Used in pharmacy management systems to track formulary updates, drug procurement timelines, and NDC-level inventory receipt for controlled substance reconciliation.

An external identifier or citation linking a drug strength record to a standard drug database source such as RxNorm, FDA NDC directory, or First Databank. Used in pharmacy systems to validate concentration values against authoritative drug knowledge references and maintain formulary accuracy.

The date on which a drug strength record was retired, superseded, or resolved within the medication database, such as when a concentration is removed from formulary or replaced by an updated NDC. Used in pharmacy systems to manage historical drug strength lifecycle and support audit trails.

The respiratory rate measurement associated with a medication strength assessment or clinical observation, used to evaluate patient response to a drug concentration. Captured in clinical documentation systems to correlate vital signs with medication dosing decisions in inpatient or emergency care settings.

The outcome of a drug concentration measurement or laboratory assay, such as a serum drug level test confirming therapeutic range compliance. Used in clinical and pharmacy systems to document whether a prescribed medication strength achieved the intended therapeutic effect based on lab or clinical findings.